跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,926 条关于
“SMETI inhibitor”
全部
19,926
临床试验
9,769
药物
4,083
机构
20
资讯
6,054
去年
Kazia Therapeutics Sells Cantrixil Intellectual Property Rights to Vivesto for $1 Million
去年
Gilteritinib Shows Promise as ALK Inhibitor in Acute Myeloid Leukemia
2年前
Merck's Bomedemstat Shows Promise as Irreversible LSD1 Inhibitor for MPNs
2年前
FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH
9个月前
Dizal Reports Promising Hematology Data at ASH 2025 with JAK1 Inhibitor Golidocitinib and Dual BTK/LYN Inhibitor Birelentinib
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
2年前
BridgeBio's BBO-8520: A Novel KRAS(G12C) Inhibitor Shows Promise in NSCLC
去年
KRAS Inhibitor Market to Reach $186.4 Million by 2033, Driven by Targeted Cancer Therapies
2年前
MAIA Biotechnology's Shares Surge Following FDA Approval of Telomerase Inhibitor
第 1 页,共 606 页
上一页
下一页